Improving Empiric Antibiotic Selection for Patients with Cancer Hospitalized with Infection: Secondary Analysis of the INSPIRE Trials
Antimicrobial Stewardship & Healthcare Epidemiology · 2026-08 · 6 (S1) · s1-s1
DOI: 10.1017/ash.2026.10431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 23.06.2026. Verfasst von Shruti Gohil und 22 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Empiric extended-spectrum antibiotics are routinely given to patients with cancer despite low risk of infection with multidrug-resistant organisms (MDROs). This secondary analysis of the four INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection) trials evaluated how computerized physician order entry (CPOE) prompts providing patient- and pathogen-specific MDRO risk estimates affected empiric extended-spectrum antibiotic use in patients with cancer.
Methods
We identified non-critically ill hospitalized adults (> Results: Including all trials, 36,861 (18,272 baseline; 18,589 intervention) patients had cancer. Mean age was 69.0 (13.6); 48.0% (17,675) were male. Extended-spectrum antibiotic days-of-therapy decreased by 27% (95% CI:20-34%, PPPP Conclusions and Relevance: An antibiotic stewardship bundle that included CPOE prompts recommending standard-spectrum antibiotics for patients at low risk for antimicrobial-resistant infections reduced extended-spectrum antibiotic use in non-critically ill patients with cancer who were hospitalized with community-acquired pneumonia, UTI, abdominal infection, or SST, without observed differences in safety outcomes.
Zitieren
APA
Gohil, S., Avery, T., Kleinman, K., Septimus, E., Mauricio, A., Sands, K., Varma, N., Sljivo, S., Roemer, K., Cooper, W., Poland, R., Weinstein, R., Fakhry, S., Guy, J., Moody, J., Coady, M., Smith-Sells, K., Hayden, M., Kubiak, D., …, & Baker, M. (2026). Improving Empiric Antibiotic Selection for Patients with Cancer Hospitalized with Infection: Secondary Analysis of the INSPIRE Trials. Antimicrobial Stewardship & Healthcare Epidemiology, 6(S1), s1-s1. https://doi.org/10.1017/ash.2026.10431
Vancouver
Gohil S, Avery T, Kleinman K, Septimus E, Mauricio A, Sands K, et al. Improving Empiric Antibiotic Selection for Patients with Cancer Hospitalized with Infection: Secondary Analysis of the INSPIRE Trials. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(S1):s1-s1. doi:10.1017/ash.2026.10431
BibTeX
@article{Gohil2026,
author = {Gohil, Shruti and Avery, Taliser and Kleinman, Ken and Septimus, Ed and Mauricio, Amarah and Sands, Kenneth and Varma, Neha and Sljivo, Selsebil and Roemer, Kaleb and Cooper, William and Poland, Russell and Weinstein, Robert and Fakhry, Samir and Guy, Jefrey and Moody, Julia and Coady, Micaela and Smith-Sells, Kimberly and Hayden, Mary and Kubiak, David and Burks, Chenette and Platt, Richard and Huang, Susan and Baker, Meghan},
title = {Improving Empiric Antibiotic Selection for Patients with Cancer Hospitalized with Infection: Secondary Analysis of the INSPIRE Trials},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2026},
volume = {6},
number = {S1},
pages = {s1--s1},
doi = {10.1017/ash.2026.10431}
}
EUVIMED